(March 6, 2024, 9:00 AM EST) -- BOSTON — The Massachusetts federal judge for the Zofran birth defect multidistrict litigation will allow GlaxoSmithKline LLC (GSK) and its counsel to recover $453,989.18 in costs incurred before a federal appeals court affirmed summary judgment in all cases....